Xeris Biopharma Holdings, Inc. - Common Stock —— 季度现金流量表 (NASDAQ:XERS) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 323.06 M392.01 M334.69 M370.19 M383.53 M 负债总额 352.68 M379 M353.99 M371.05 M369.84 M 权益总额 -29.61 M13.01 M-19.3 M-861 K13.69 M 负债及股东权益总额 323.06 M392.01 M334.69 M370.19 M383.53 M 总债务 217.01 M221.22 M218.63 M219.47 M220.34 M 净债务 217.01 M109.47 M159.34 M127.87 M109.29 M

新闻

Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right (NASDAQ:XERS)

Xeris Biopharma (XERS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Xeris Pharmaceuticals在Barclays会议上展示强劲增长,RECORLEV推动业绩

Xeris Pharmaceuticals at Barclays: Strong Growth Fueled by RECORLEV

Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Xeris Biopharma (XERS) Reports Q4 Earnings: What Key Metrics Have to Say

Xeris Biopharma (XERS) Q4 Earnings and Revenues Surpass Estimates

Xeris Biopharma第四季度每股收益超预期,指引高于预期,股价上涨近3%

Xeris Biopharma stock up nearly 3% after Q4 EPS beat, above estimate guidance

Xeris PharmaceuticalsQ1每股收益及营收超出预期

Xeris Pharmaceuticals earnings beat by $0.04, revenue topped estimates

Xeris Pharmaceuticals面临盈利考验,增长势头加速